Efficacy and tolerability of intrathecal liposomal cytarabine for central nervous system embryonal tumors

被引：0
|
作者：
Partap, S. [1 ]
Murphy, P. A. [1 ]
Vogel, H. [1 ]
Barnes, P. D. [1 ]
Edwards, M. S. [1 ]
Fisher, P. G. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2064
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia
    Sommer, Constanze
    Lackner, Herwig
    Benesch, Martin
    Sovinz, Petra
    Schwinger, Wolfgang
    Moser, Andrea
    Bergloeff, Jutta
    Gruber, Anna
    Urban, Christian
    [J]. ANNALS OF HEMATOLOGY, 2008, 87 (11) : 887 - 890
  • [22] EFFICACY AND TOLERABILITY OF INTRATHECAL LIPOSOMAL CYTARABINE FOR TREATMENT OF MENINGEAL RELAPSES IN ACUTE LYMPHOBLASTIC LEUKAEMIA: EXPERIENCE OF A SINGLE PEDIATRIC INSTITUTION
    Parasole, R.
    Menna, G.
    Marra, N.
    Mangione, A.
    Buffardi, S.
    Misuraca, A.
    Petruzziello, E.
    Poggi, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 2 - 3
  • [23] SAFETY AND TOLERABILITY OF INTRATHECAL LIPOSOMAL CYTARABINE AS CNS PROPHYLAXIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Neumeister, P.
    Schmidt, H.
    Linkesch, W.
    Pfeilstoecker, M.
    Rohn, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 261 - 261
  • [24] Safety and tolerability of intrathecal liposomal cytarabine as cns prophylaxis in patients with acute lymphoblastic leukemia
    Neumeister, P. N.
    Pfeilstöcker, M.
    Linkesch, W.
    Rohn, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 8 - 9
  • [25] Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors
    Yi-Peng Han
    Chen-Kai Ma
    Shen-Qi Wang
    Atsushi Enomoto
    Yang Zhao
    Masahide Takahashi
    Jie Ma
    [J]. Journal of Neuro-Oncology, 2014, 119 : 343 - 351
  • [26] Gene expression profiling to analyze embryonal tumors of the central nervous system
    Roger J. Packer
    [J]. Current Neurology and Neuroscience Reports, 2003, 3 (2) : 117 - 119
  • [27] Embryonal Tumors of Central Nervous System: Single Center Treatment Experience
    Oksel, A.
    Ince, D.
    Kizmazoglu, D.
    Kizmazoglu, C.
    Demiral, A.
    Cetingoz, R.
    Kuru, A.
    Guleryuz, H.
    Ozer, E.
    Olgun, Nur
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S181 - S181
  • [28] Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors
    Han, Yi-Peng
    Ma, Chen-Kai
    Wang, Shen-Qi
    Enomoto, Atsushi
    Zhao, Yang
    Takahashi, Masahide
    Ma, Jie
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (02) : 343 - 351
  • [29] Central nervous system (CNS) prophylaxis in elderly patients with aggressive B cell non Hodgkin lymphoma (NHL) and acute leukemia (AL): Safety and efficacy of intrathecal liposomal cytarabine
    Bongarzoni, V
    Anaclerico, B.
    Cedrone, M.
    Chierichini, A.
    Fenu, S.
    Bartolini, M.
    Ronci, B.
    Anticoli, F.
    Iacovino, P.
    Annino, L.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 192 - 192
  • [30] Liposomal cytarabine for central nervous system (CNS) relapse in acute promyelocytic leukemia (APL).
    Castagnola, Carlo
    Lunghi, M.
    Calatroni, S.
    Lazzarino, M.
    [J]. BLOOD, 2006, 108 (11) : 227B - 227B
12345